1. Home
  2. VERU vs OPXS Comparison

VERU vs OPXS Comparison

Compare VERU & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • OPXS
  • Stock Information
  • Founded
  • VERU 1971
  • OPXS 1987
  • Country
  • VERU United States
  • OPXS United States
  • Employees
  • VERU N/A
  • OPXS N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • OPXS Electronic Components
  • Sector
  • VERU Health Care
  • OPXS Technology
  • Exchange
  • VERU Nasdaq
  • OPXS Nasdaq
  • Market Cap
  • VERU 85.5M
  • OPXS 75.8M
  • IPO Year
  • VERU 1990
  • OPXS N/A
  • Fundamental
  • Price
  • VERU $3.45
  • OPXS $11.89
  • Analyst Decision
  • VERU Strong Buy
  • OPXS
  • Analyst Count
  • VERU 3
  • OPXS 0
  • Target Price
  • VERU $33.33
  • OPXS N/A
  • AVG Volume (30 Days)
  • VERU 139.0K
  • OPXS 48.9K
  • Earning Date
  • VERU 08-12-2025
  • OPXS 08-12-2025
  • Dividend Yield
  • VERU N/A
  • OPXS N/A
  • EPS Growth
  • VERU N/A
  • OPXS 23.32
  • EPS
  • VERU N/A
  • OPXS 0.75
  • Revenue
  • VERU $16,886,419.00
  • OPXS $39,481,000.00
  • Revenue This Year
  • VERU N/A
  • OPXS N/A
  • Revenue Next Year
  • VERU N/A
  • OPXS N/A
  • P/E Ratio
  • VERU N/A
  • OPXS $15.85
  • Revenue Growth
  • VERU 337.24
  • OPXS 21.00
  • 52 Week Low
  • VERU $2.64
  • OPXS $5.36
  • 52 Week High
  • VERU $14.20
  • OPXS $14.60
  • Technical
  • Relative Strength Index (RSI)
  • VERU 42.63
  • OPXS 53.90
  • Support Level
  • VERU $3.24
  • OPXS $11.05
  • Resistance Level
  • VERU $3.94
  • OPXS $12.00
  • Average True Range (ATR)
  • VERU 0.22
  • OPXS 0.75
  • MACD
  • VERU 0.10
  • OPXS 0.12
  • Stochastic Oscillator
  • VERU 31.94
  • OPXS 95.13

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.

Share on Social Networks: